MedTrace Logo

Transcranial Magnetic Stimulation for Facial Pain

NCT02633306 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2021-04-08

Study results available
· View outcomes & findings →

Summary

Complex oro-facial pain is a poorly diagnosed and poorly treated cause of significant suffering and disability. This study will explore the ability of fMRI to identify patients with complex oro-facial pain who respond to transcranial magnetic stimulation therapy.

Specific Aims:

1. To establish baseline patterns of MRI in patients with chronic oro-facial pain without a definitive etiologic diagnosis.
2. To estimate the rate of treatment success of transcranial stimulation of the primary motor cortex (M1) in these patients.
3. To identify post-treatment MRI patterns that are associated with treatment success.

Conditions

  • Trigeminal Nerve Injuries
  • Post-herpetic Neuralgia
  • Facial Pain
  • Nervus Intermedius Neuralgia

Interventions

DEVICE

transcranial magnetic stimulation

Treatment will consist of five daily sessions of transcranial magnetic stimulation of the motor cortex contralateral to the pain.

Sponsors & Collaborators

Principal Investigators

  • Stephen J Haines, MD · University of Minnesota

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
110 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-01
Primary Completion
2019-07-01
Completion
2019-08-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02633306 on ClinicalTrials.gov